Evidence map›Paper›PMID 40761191›Full record

ArticleAME case reports2025

SMARCB1/INI1-deficient lung cancer with lymph node metastasis: a case report and literature review.

Xuemin Yang, Mingming Wang, Dan Qiu, Huanhuan Zhang, Wenrui Jiang

Abstract readCase Reports
In one paragraph

Article in AME case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Xuemin Yang *Department of Pulmonary and Critical Care of Medicine, The First Affiliated Hospital of the Air Force Military Medical University, Xi'an, China.
Mingming Wang *Department of Pulmonary and Critical Care of Medicine, The First Affiliated Hospital of the Air Force Military Medical University, Xi'an, China.
Dan QiuDepartment of Pulmonary and Critical Care of Medicine, The First Affiliated Hospital of the Air Force Military Medical University, Xi'an, China.
Huanhuan ZhangDepartment of Pulmonary and Critical Care of Medicine, The First Affiliated Hospital of the Air Force Military Medical University, Xi'an, China.
Wenrui JiangDepartment of Pulmonary and Critical Care of Medicine, The First Affiliated Hospital of the Air Force Military Medical University, Xi'an, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Switch/Sucrose non-fermentable-related, matrix-associated, actin-dependent regulator of chromatin subfamily B member 1/integrase interactor 1 (SMARCB1/INI1)-deficient lung cancer is a very rare and highly invasive malignant tumor, of which clinicians and pathologists often have limited understanding. Case Description: We present a 54-year-old man with SMARCB1/INI1-deficient lung cancer, pathologically confirmed by computed tomography guided percutaneous pulmonary mass biopsy and ultrasound-guided lymph node biopsy. Both lymphoids and lung tissues showed INI1 deletion and high Ki-67 index; next generation sequencing (NGS) indicated a tumor protein 53 ( Conclusions: We provided the clinical symptoms, imaging data, and literature findings of this rare case of SMARCB1/INI1-deficient lung cancer with lymph node metastasis as a reference, hoping to help clinicians and pathologists have a better understanding of it and avoid misdiagnosis.

Indexed as

case reportlymph node metastasisrare malignant tumorSwitch/Sucrose non-fermentable-related, matrix-associated, actin-dependent regulator of chromatin subfamily B member 1/integrase interactor 1-deficient lung cancer (SMARCB1/INI1-deficient lung cancer)

Identifiers

PMID40761191
PMCPMC12319588

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.